Objective. The aim of this systematic review was to summarize and evaluate the existing evidence on the effectiveness and safety of acupuncture in relieving chronic pain-related depression (CPRD). Methods. We searched seven online databases to identify eligible randomized controlled trials (RCTs) of acupuncture for CPRD published before September 2020. We included studies that used acupuncture as the intervention group, with or without a control group, and the control group was treated with conventional drugs. Meta-analysis was performed using RevMan 5.3 software. For outcomes, assessments were performed using the Hamilton Depression Scale (HAMD), Visual Analogue Scale (VAS), and adverse events. Results. Eight studies involving 636 participants were identified and included in the meta-analysis. The results showed that single acupuncture treatment and drug treatment have the same effect in improving the HAMD score (MD = −0.14, 95% CI = [−0.88, 0.59], = 0.71) and alleviating the VAS score (MD = −0.42, 95% CI = [−1.10, −0.27], = 0.23), but acupuncture treatment is safer (OR = 0.03, 95% CI = [0.01, 0.21], = 0.0003). In addition, acupuncture combined with drugs (control group) is more beneficial than single-drug treatment in improving the HAMD score (MD = −2.95, 95% CI = [−3.55, −2.36], < 0.00001) and alleviating the VAS score (MD = −1.06, 95% CI = [−1.65, −0.47], = 0.0004). Conclusion. Acupuncture is an effective and safe treatment for CPRD, and acupuncture combined with drug therapy is more effective than single-drug therapy. Nevertheless, the conclusions were limited due to the low quality and a small number of included studies.
Background. Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder with recurrent abdominal pain and altered defecation habits. We here attempted to determine the effect of acupuncture on IBS. Methods. Randomized controlled trials (RCTs) published in CNKI, VIP, Wanfang, PubMed, Cochrane Library, EMBASE, Web of science, and ClinicalTrials.gov till July 17, 2019 were searched. Outcomes were total efficacy rates, overall IBS symptom scores, or global quality of life scores. Standardized mean difference (SMD) with 95% confidence intervals (CI) and risk ratio (RR) with 95% CI were calculated for meta-analysis. Results. We included 41 RCTs involving 3440 participants for analysis. 8 RCTs compared acupuncture with sham acupuncture, among which 3 trials confirmed the biological effects of acupuncture, especially in treating abdominal pain, discomfort, and stool frequency. No significant difference was found when acupuncture was compared with sham acupuncture, in terms of effects on IBS symptoms and quality of life (SMD = 0.18, 95% CI −0.26∼0.63, ; SMD = −0.10, 95% CI −0.31∼0.11, ), but the pooled efficacy rate data showed a better outcome for true acupuncture (RR = 1.22, 95% CI 1.01∼1.47, ), which was not supported by sensitivity analysis. Acupuncture was more effective relative to western medicine in alleviating IBS symptoms (RR = 1.17, 95% CI 1.12∼1.23, I2 = 0%, ), whose effect might last 3 months. Besides, acupuncture as an adjunct to western medicine, Chinese medications, or tuina was superior over the single latter treatment (RR = 1.68, 95% CI 1.18 to 2.40, ; 1.19, 1.03 to 1.36, ; 1.36, 1.08 to 1.72, , respectively), with high heterogeneities. Conclusions. Relative to sham controls, acupuncture showed no superiority for treating IBS, while the advantage over western medicine was significant. Acupuncture could be used as an adjunct in clinical settings to improve efficacy. Future high-quality and large-sample-size studies with adequate quantity-effect design need to be conducted.
1 October 2013 in Journal of Traditional Chinese Medicine
Objective: To compare the curative effects of heat-sensitive moxibustion with conventional drugs on chronic persistent asthma and seek a valuable therapy to replace Western Medicine. Methods: The participants in this multi-center, randomized, and controlled study were randomly divided into two groups: group A (n=144), treated with heat-sensitive moxibustion (50 sessions) and group B (n=144), treated with Seretide (salmeterol 50 µg/fluticasone 250 µg, twice a day). The scores of asthma control test (ACT), forced expiratory volume in 1 second (FEV1), peak expiratory flow (PEF), and attack frequency were measured after 15, 30, 60, and 90 days of treatment. Patients followed up 3 and 6 months after treatment. Results: There was a significant difference (P= 0.0002) in the ACT score and lung function between the two groups after 3 months of treatment and (P=0.000 03) during the follow-up visits. In addition, heat-sensitive moxibustion reduced attack frequency in the period from inclusion to the 6-month follow-up visit. Conclusion: This study shows that heat-sensitive moxibustion may have a comparable curative effect to Seretide(salmeterol/fluticasone) on asthma.
Background: Acupuncture therapy has already extensively used in many countries around the world to treat primary dysmenorrhea. But there is no bibliometric analysis on this aspect. Therefore, the purpose of this study is to evaluate the research trends of acupuncture therapy in the treatment of primary dysmenorrhea through literature research from 2001 to 2021 by using Citespace 6.1.R1(64-bit) Basic. Methods: Relevant literature is extracted from the Web of Science database. CiteSpace conducts cooperative network analysis on the information of authors, countries and institutions, co-occurrence network analysis on keywords, and co-citation analysis on cited journals, cited authors and cited references. Results: A total of 189 publications were extracted from 2001 to 2021. The total numbers of publication have steadily increased over the past two decades, and we have identified the most active countries, institutions, journals and authors in the field of acupuncture for primary dysmenorrhea. The EVID-BASED COMPL ALT was the most productive journal, and the COCHRANE DB SYST REV with the highest IF. The first in the frequency and centrality is the journal of AM J OBSTET GYNECOL. The most productive country and institution are China and Beijing University Chinese Medicine. YANG J was the most prolific author and CHEN H had the highest citation counts. The centrality of cite references ranked the first conducted by Burnett M. The keyword of “primary dysmenorrhea” ranked first for research developments with the highest frequency. Conclusion: The research results of Metrology in this paper provide the current situation and trend of clinical research on primary dysmenorrhea acupuncture Therapy in recent twenty-one years, which is helpful for researchers to identify the hot spots in this field and explore new directions of future research.
1 January 2014 in Evidence-Based Complementary and Alternative Medicine
Systematic reviews of moxibustion for LDH have identified ponderable evidence, especially for heat‐sensitive moxibustion (HSM). Therefore, we designed and carried out the large sample trial to evaluate it. 456 patients were recruited from 4 centers in China and were randomly divided into three groups by the ratio of 1 : 1 : 1 to HSM (152) group, conventional moxibustion (152) group, and conventional drug plus acupuncture (152) group. Compared with usual care, there was a statistically significant reduction in mean M‐JOA score at 2 weeks and 6 months for HSM (3.8 ± 2.6 versus 8.5 ± 2.9; 3.7 ± 2.2 versus 10.1 ± 2.9) and conventional moxibustion (7.9 ± 3.0 versus 8.5 ± 2.9; 8.9 ± 3.1 versus 10.1 ± 2.9). Compared with conventional moxibustion group, HSM group showed greater improvement in all the outcomes. The mean dose of moxibustion was 41.13 ± 5.26 (range 21–60) minutes in the HSM group. We found that HSM was more effective in treating patients with LDH, compared with conventional moxibustion and conventional drug plus acupuncture. This finding indicated that the application of moxibustion on the heat‐sensitive points is a good moxibustion technique in treating disease.
1 January 2013 in Evidence-Based Complementary and Alternative Medicine
Substantial evidence has supported that moxibustion stimulates a unique phenomenon of Deqi, heat-sensitive moxibustion sensation. This study consisted of a multicenter, prospective cohort study with two parallel arms (A: heat-sensitive moxibustion sensation group; B: nonheat-sensitive moxibustion sensation group). All forms of moxibustion were applied unilaterally on the right leg with a triangle shape of three acupuncture points simultaneously (bilateral Xi Yan (EX-LE5) and He Ding (EX-LE2)). After one month the primary outcome parameter GPCRND-KOA showed significant differences between groups: trial group 5.23 ± 2.65 (adjusted mean ± SE) 95% CI [4.44~6.01] versus control group 7.43 ± 2.80 [6.59~8.26],. Significant differences were manifested in total M-JOA score during the follow-up period (). Mean knee circumference indicated significant difference between the groups (;). Overall, this evidence suggested that the effectiveness of the Deqi sensation group might be more superior than the non-Deqi sensation one in the treatment of KOA. This study was aimed at providing scientific evidence on the Deqi sensation of moxibustion and at showing that heat-sensitive moxibustion sensation is essential to achieve the preferable treatment effects of KOA.